Algorhythm net loss from continuing operations widens to $4.15 million in Q2 FY26; net sales more than doubled to $3.01 million
RIME•Quarterly results and costs
Algorhythm reported net sales of $3.01 million for the quarter ended June 30, 2026, up 160.85% year over year.
Net loss from continuing operations widened to $4.15 million from $1.24 million a year earlier.
Cost of sales climbed to $3.6 million, while operating expenses rose to $2.11 million.
Other expenses increased to $1.45 million, driven by higher interest expense and a $400,000 loss on debt extinguishment.
Liquidity and going-concern warning
Cash and restricted cash totaled $7.96 million at June 30, 2026; management flagged substantial doubt about the company’s going-concern ability.
